Number of the records: 1  

sunitinib

  1. Topical termsunitinib
    See link5-(5-Fluoro-2-oxo-1,2-dihydroindolylidenemethyl)-2,4-dimethyl-1H-pyrrole-3-carboxylic acid (2-diethylaminoethyl)amide (UF)
    SU 011248 (UF)
    SU 11248 (UF)
    SU-011248 (UF)
    SU-11248 (UF)
    SU011248 (UF)
    SU11248 (UF)
    sunitinib malát (UF)
    Sunitinib Malate (UF)
    Sutent (UF)
    See alsoindoly
    pyrroly
    antitumorózní látky (PA)
    inhibitory angiogeneze (PA)
    inhibitory proteinkinas (PA)
    Linking entrySunitinib
    ConspectD03. - 383. - 129. - 578. - 823
    D03. - 633. - 100. - 473. - 877
    NoteAn indole and pyrrole derivative that inhibits VEGFR-2 and PDGFR BETA RECEPTOR TYROSINE KINASES. It is used as an antineoplastic agent for the treatment of GASTROINTESTINAL STROMAL TUMORS, and for treatment of advanced or metastatic RENAL CELL CARCINOMA.
    DatabaseMESH
    References (2) - MESH
    subject heading

    subject heading

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.

Accept allSettingsReject all